Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 5, 2007, Pages 353-356

  Soriano, A ^a   Gomez J ^b   Gomez L ^c   Azanza, J R ^d   Perez R ^e   Romero, F ^f   Pons, M ^g   Bella, F ^h   Velasco, M ⁱ   Mensa, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Pathology Department Hospital Virgen Arreixaca   (Spain)

^c HOSPITAL MÚTUA DE TERRASSA   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e Althaia   (Spain)

^f Hospital FREMAP   (Spain)

^g Hospital Sant Rafael   (Spain)

^h HOSPITAL DE TERRASSA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; RIFAMPICIN;

ADD ON THERAPY; ADULT; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORYNEBACTERIUM; DEVICE INFECTION; DEVICE REMOVAL; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOLERANCE; DRUG WITHDRAWAL; EYE DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; MALE; NAUSEA AND VOMITING; ORTHOPEDIC EQUIPMENT; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL;

ACETAMIDES; ADMINISTRATION, ORAL; AGED; ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; JOINT PROSTHESIS; MALE; MIDDLE AGED; OXAZOLIDINONES; PROSTHESIS-RELATED INFECTIONS; TREATMENT OUTCOME;

EID: 34248186121     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-007-0289-1     Document Type: Article

References (13)

1. Brandt CM, Duffy MC, Berbari EF, Hanssen AD, Steckelberg JM, Osmon DR (1999) Staphylococcus aureus prosthetic joint infection treated with prosthesis removal and delayed reimplantation arthroplasty. Mayo Clin Proc 74:553-558
2. Zimmerli W, Frei R, Widmer AF, Rajacic Z (1994) Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 33:959-967
3. Tice AD, Hoaglund PA, Shoultz DA (2003) Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 51:1261-1268
4. Houshian S, Zawadski AS, Riegels-Nielsen P (2000) Duration of postoperative antibiotic therapy following revision for infected knee and hip arthroplasties. Scand J Infect Dis 32:685-688
5. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. JAMA 279:1537-1541
6. Tsukayama DT, Estrada R, Gustilo RB (1996) Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Jt Surg Am 78:512-523
7. Bassetti M, Vitale F, Melica G, Righi E, Di Biagio A, Molfetta L et al (2005) Linezolid in the treatment of gram-positive prosthetic joint infections. J Antimicrob Chemother 55:387-390
8. Bassetti M, Di Biagio A, Cenderello G, Del Bono V, Palermo A, Cruciani M et al (2001) Linezolid treatment of prosthetic hip infections due to methicillin-resistant Staphylococcus aureus. J Infect 43:148-149
9. Jover-Saenz A, Gaite FB, Ribelles AG, Porcel-Perez JM, Garrido-Calvo S (2003) Linezolid treatment of total prosthetic knee infection due to methicillin-resistant Staphylococcus epidermidis. J Infect 47:87-88
10. Senneville E, Legout L, Valette M, Yazdanpanah Y, Beltrand E, Caillaux M et al (2006) Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study. Clin Ther 28:1155-1163
11. Rao N, Ziran BH, Wagener MM, Santa ER, Yu VL (2004) Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections. Clin Infect Dis 38:1058-1064
12. Bressler AM, Zimmer SM, Gilmore JL, Somani J (2004) Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 4:528-531
13. Rucker JC, Hamilton SR, Bardenstein D, Isada CM, Lee MS (2006) Linezolid-associated toxic optic neuropathy. Neurology 66:595-598